Opicapone
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Opicapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 24, 2020. In 2024, Medicare Part D spent $15 million on Opicapone across 17,000 claims for 3,276 beneficiaries.
Opicapone is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $24.67 to $24.76 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$24.67 – $24.76
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Catechol-O-Methyltransferase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing OPICAPONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ONGENTYS 50 MG CAPSULE | $24.7603 per EA | -0.01% |
ONGENTYS 25 MG CAPSULE | $24.6680 per EA | — |
Frequently Asked Questions
What is Opicapone used to treat?
Opicapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Opicapone?
In 2024, Medicare Part D spent $15 million on Opicapone across 17,000 claims for 3,276 beneficiaries.
How many Opicapone products are on the market?
The Opicapone drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Opicapone?
NADAC reference prices for Opicapone range from $24.6680 to $24.7603 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Opicapone?
1 manufacturer lists Opicapone in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals LLC (2).
How has the price of Opicapone changed recently?
Over the past 7 days, 0 Opicapone NDCs rose and 1 fell, with a market-wide average change of -0.0%.